Episode 890: Conexeu Sciences ($CNXU): Advancing 3D-Printed Tissue Regeneration for Breast Reconstruction

This interview is disseminated on behalf of Conexeu Sciences Inc.

Conexeu Sciences (NASDAQ: CNXU) Chief Scientific Officer and Co-Founder Dr. Claudia Chavez-Munoz, MD, PhD, joins Stocks To Watch to discuss the company's investigational B.R.E.A.S.T.™ program and its potential application in breast reconstruction. She highlights the program's preclinical development in collaboration with the Wake Forest Institute for Regenerative Medicine, its 3D-printed tissue scaffold technology, and the potential of Conexeu's extracellular matrix platform.

Learn more: https://www.conexeu.com/

Watch the full YouTube interview here: https://youtu.be/RFEsagJce8g
And follow us to stay updated: https://www.youtube.com/@stockstowatchofficial